Stock screenerAll disclosures →
EDGAR →
SPRY
Conviction 3HealthcareScan · Fri, Aug 7, 2026SPRY$6.16+10.90%
ResistanceSupportVol 14Insider sell2
Vol MA14 2.72M
May 8May 27Jun 15Jul 2Jul 22Aug 7
Price6.16
Change+10.90%
Gap+2.34%
Rel volume1.13×
Avg volume2.48M
Avg $ vol15.21M
SMA 206.20
SMA 507.88
SMA 2008.87
Price vs 50-21.92%
Price vs 200-30.58%
MA stackbearish
50/200 cross—
Supertrenddown · 6.69
RSI (14)44
MACD hist0.07
MACD crossbull · 0d
Stoch %K / %D73 / 40
ADX (14)39
+DI / −DI19 / 30
RSI divergence—
MACD divergenceBullish
ATR %+7.72%
ADR %6.80%
52w high17.65
52w low5.13
From 52w high-65.13%
Above 52w low+19.98%
New 52w highNo
SqueezeOff
Bollinger width52.31%
%B0.49
Donchian pos42.13%
Donchian high7.87
Donchian low4.91
AVWAP (52w high)9.50
vs AVWAP high-35.20%
AVWAP (52w low)5.52
vs AVWAP low+11.59%
OBV trendDown
Chaikin MF (20)0.02
Today vs 20d1.13×
Avg vol (14d)2.72M
Avg vol (20d)2.48M
Avg $ vol (20d)15.21M
Market cap611.21M
RS 3m (vs SPY)-44.93%
RS 6m (vs SPY)-57.27%
RS line new highNo
Trend template0/8
Technical rank13.6
1 week+19.98%
1 month-21.89%
3 months-31.61%
6 months-36.35%
1 year-65.77%
YTD-46.43%
P/E-3.57
P/B9.97
P/S7.25
P/FCF-3.57
EPS-1.74
Div yield—
ROE-279.41%
ROA-59.57%
Debt/Eq1.57
Current4.94
EV/EBITDA-3.82
Gross margin—
Net margin-203.25%
Rev growth-5.46%
EPS growth-2241.76%
Price target30.00
Target upside387.41%
Analyst ratingBuy
Institutional100.12%
Ent. value683.41M
Revenue22.68M
Net income-60.62M
Gross profit—
Free cash flow-171.21M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out99.3M
Employees159
ListedWed, Nov 9, 2022
Free float36.1M
Float %36.4%
Short interest22.67M
Days to cover15.3d
Short volume76.2%
Squeeze score87 / 100
Next earningsThu, Aug 13, 2026 · after (6d)
EPS forecast−$0.55 · 2 est
Last EPS vs est−$0.61 vs −$0.53
Last surprise-15.1% miss
Setup gradeD
Conviction3 / 100
Pattern quality—
Tech rank13.6 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance9.77
Support6.20
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in SPRY
No recent disclosed trades by Congress in SPRY. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in SPRY · 9 buys · 1 sell
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
SCHNEIDER PHILLIP M Director · Stock Option (right to buy) · 2026-06-24 | Grant | 30K | — | 2026-06-24 | 2026-06-26 |
RA CAPITAL MANAGEMENT, L.P. Director · Stock Option (Right to Buy) · 2026-06-24 | Grant | 30K | — | 2026-06-24 | 2026-06-26 |
SAUNDERS BRENT L Director · Stock Option (right to buy) · 2026-06-24 | Grant | 30K | — | 2026-06-24 | 2026-06-26 |
Islam Saqib Director · Stock Option (right to buy) · 2026-06-24 | Grant | 30K | — | 2026-06-24 | 2026-06-26 |
Shah Pratik Director · Stock Option (right to buy) · 2026-06-24 | Grant | 30K | — | 2026-06-24 | 2026-06-26 |
Kelly Michael Director · Stock Option (right to buy) · 2026-06-24 | Grant | 30K | — | 2026-06-24 | 2026-06-26 |
Dadoo Rajeev Director · Stock Option (right to buy) · 2026-06-24 | Grant | 30K | — | 2026-06-24 | 2026-06-26 |
Shawver Laura Director · Stock Option (right to buy) · 2026-06-24 | Grant | 30K | — | 2026-06-24 | 2026-06-26 |
Thompson Peter A. Director · Stock Option (right to buy) · 2026-06-24 | Grant | 30K | — | 2026-06-24 | 2026-06-26 |
Fitzpatrick Alexander A Chief Legal Officer · Common Stock · 2026-06-12 | Sell | 3.35K | $34K | 2026-06-12 | 2026-06-12 |
SEC filings
EDGAR filings in SPRY · 7 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.